Optimizing a digital support service for concerned significant others of individuals with SUD with helpline, AI-enhanced and peer-led support
Active Project Grant Awarded Last action
- Award ID
- R61DA064828
- Recipient
-
Partnership To End Addiction UEI NDKHVACPA8A6
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $453,750
Award facts
- Assistance listing
- 93.279 Drug Use and Addiction Research Programs
- Completion date 31% complete
- Place of performance
- New York, NY 10017, USA
Award details come from USAspending.gov.
About this award
The National Institute on Drug Abuse awarded Partnership To End Addiction $453,750 on March 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop and evaluate HALO, an AI-powered chatbot delivering evidence-based support to concerned significant others of individuals with substance use disorder.
HALO will integrate with Partnership's existing helpline platform, which serves over 23,000 families annually through phone, text, automated messaging, peer support, and e-learning. In the R61 phase, the recipient will apply natural language processing techniques to analyze 40,000 or more helpline interactions, conduct surveys and interviews with concerned significant others, individuals with substance use disorder, and peer coaches, and use user-centered design to develop HALO. A three-month pilot trial with 60 participants will assess feasibility, usability, engagement, and preliminary effects on family recovery capital, concerned significant other functioning, and substance use across three conditions: helpline only; helpline plus HALO; and helpline plus HALO plus peer support. Meeting predefined feasibility benchmarks will determine progression to the R33 phase, where the recipient will conduct a six-month, 2-by-2 factorial trial with 800 participants to evaluate the individual and combined effects of HALO and peer support.
The award period runs from March 15, 2026, through February 29, 2028. Work is performed in New York, New York.
Description
- Abstract
- Families of individuals with substance use disorder (SUD) experience high levels of distress and limited access to evidence-based support. Concerned significant others (csos), particularly parents and caregivers, often struggle to navigate their loved one's (LO) substance use and treatment options due to stigma, financial barriers, and systemic exclusion from care. While family involvement improves treatment engagement and recovery outcomes, few scalable interventions exist to provide structured, ongoing support to csos. Digital interventions, including AI-driven chatbots, have the potential to increase accessibility and engagement; however, no AI-based models are currently designed to deliver tailored, evidence-based support to csos. This R61/R33 study will develop and evaluate halo (helping affected loved ones), an AI-powered chatbot designed to provide real-time, structured guidance to csos within a digital family support ecosystem. Halo will be integrated into the partnership to end addiction's helpline, which serves over 23,000 families annually through phone, text, automated messaging, peer support, and e-learning. In the R61 phase, we will apply natural language processing (NLP) techniques to analyze 40,000+ helpline interactions, conduct surveys and interviews with csos, LOS, and peer coaches, and use a user-centered design approach to develop halo. A three-month pilot trial (n=60) will assess feasibility, usability, engagement, and preliminary effects on family recovery capital, CSO functioning, and LO substance use across three conditions: (1) helpline (HL) only; (2) HL + halo; and (3) HL + halo + peer support (PS). Meeting predefined feasibility benchmarks will determine progression to the R33 phase, where we will conduct a six-month, 2X2 factorial trial (n=800) to evaluate the individual and combined effects of helpline, halo, and PS on CSO and LO outcomes. A sub-sample of 200 LOS will be assessed at three months to examine the experiences and perceptions of LOS and their relationship with csos on their recovery. This study will provide the first rigorously tested AI-human hybrid support model for csos and generate data on the comparative and combined effects of AI-driven and peer- based support interventions in a representative group of csos with different needs. Findings will expand real- world tools for csos by integrating halo into the partnership's free digital support ecosystem and making IT available to treatment and community-based services that lack formal family support interventions.
Quick answers
Who received award R61DA064828?
R61DA064828 was awarded to Partnership To End Addiction by National Institute on Drug Abuse (National Institutes of Health) on March 15, 2026.
How much is award R61DA064828 worth?
$453,750 has been obligated on R61DA064828.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award